Remove 2018 Remove Leads Remove Medical science
article thumbnail

Impact of Marketing Strategies in Healthcare Systems

Medico Reach

According to research conducted in 2018 , around 27.5 million citizens of the United States of America didn’t have access to proper medical services. However, proper healthcare marketing has made prospects more aware of company insurance and other medical schemes. Importance of Marketing Strategies in Healthcare Systems.

article thumbnail

Progressing personalised cell therapies in oncology

European Pharmaceutical Review

About the interviewee Imran Khan, MD, PhD is Vice President Medical Affairs, Hematology at Johnson & Johnson Innovative Medicine. Most recently, Imran has served as Medical Science Liaison (MSL) Head, Oncology U.S. Medical Affairs.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation

Medgadget

This leads to substantial damage to healthy tissues and too often results in poor outcomes. This will hopefully lead to an FDA approval for its first indication, after which Alpha TAU plans on expanding to other types of cancer and geographic regions such as Europe and Japan. Results from initial clinical trials were quite impressive.

article thumbnail

Five Ways Asia Pacific Life Science Industry Leaders Are Enhancing Customer Experience

Veeva

This engagement is continuing to remain high, with evolving requirements and preferences of healthcare practitioners (HCPs) in the ways they engage with pharma reps and medical science liaisons (MSLs) through virtual communications. We have identified five steps to delivering more engaging customer experiences with HCPs and patients.

Pharma 52
article thumbnail

Targeted therapies for chronic lymphocytic leukaemia in an evolving treatment landscape

European Pharmaceutical Review

1 The cancer is a slow-growing but potentially life-threatening B-cell malignancy, in which increased activation of B-cell receptor signalling pathways leads to overgrowth of lymphocytes in bone marrow and other disease compartments. About the author Dr Mehrdad Mobasher, MPH, is the Chief Medical Officer for Hematology at BeiGene.

Safety 52